Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 6:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2017–2040 of 6,923 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Overactive Bladder (OAB)
Interventions: Wearable neurostimulation system for saphenous nerve stimulation, tolterodine tartrate 4 mg extended release; Device · Drug
Lead sponsor: NinaMED Pty Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
Interventions: sargramostim; Biological
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2007
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Parkinson Disease, Dysarthria
Interventions: Not listed
Lead sponsor: Jeremy Greenlee; Other
Eligibility: 21 Years to 84 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Stroke
Interventions: ReIn-Hand, Robot; Device
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: Acute Ischemic Stroke
Interventions: transcutaneous auricular vagal nerve stimulation, Sham transcutaneous vagal nerve stimulation; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 99 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: PTSD - Post Traumatic Stress Disorder
Interventions: Accelerated functional-connectivity guided transcranial magnetic stimulation; Device
Lead sponsor: Cognitive FX; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Provo, Utah

Conditions: VNS Implanted Tinnitus Patients
Interventions: Vagus Nerve Stimulation; Device
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 18 Years to 70 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Richardson, Texas

Conditions: Parkinson's Disease
Interventions: Transcranial direct current stimulation; Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 40 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Chronic Pain
Interventions: Spinal cord stimulation (SCS), Dorsal root ganglion stimulation (DRG); Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Timeline: 2019 – 2029
U.S. locations: 30
States / cities: Phoenix, Arizona • Tucson, Arizona • Larkspur, California + 24 more

Conditions: Leukemia
Interventions: Alemtuzumab, Rituximab, Sargramostim; Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 120 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Scottsdale, Arizona • Rochester, Minnesota

Conditions: Major Depressive Disorder, Epilepsy
Interventions: Intracranial electrodes, TMS; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Stanford, California

Conditions: Chronic Kidney Disease, Anemia
Interventions: Epoetin, Peginesatide; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 5
States / cities: Sacramento, California • San Diego, California • San Jose, California + 2 more

Conditions: Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Interventions: Blinatumomab, Standard of Care Chemotherapy; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 405 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 16
States / cities: Duarte, California • Los Angeles, California • San Francisco, California + 12 more

Conditions: Major Depression, Major Depression Disorders
Interventions: Transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Complex Regional Pain Syndromes
Interventions: Transcranial Magnetic Stimulation (TMS); Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Redwood City, California

Conditions: Self-reported Symptoms of Depression
Interventions: Self-help information based on principles of behavioral activation, Self-help information based on principles of cognitive restructuring; Behavioral
Lead sponsor: Trustees of Princeton University; Other
Eligibility: 18 Years and older
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Autism Spectrum Disorder
Interventions: 1 Hz Auricular transcutaneous electrical nerve stimulation, 20 Hz Auricular transcutaneous electrical nerve stimulation; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Transcranial Electrical Stimulation (tES)
Interventions: Transcranial electrical stimulation (tES) including SHAM; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 45 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Adult Solid Neoplasm
Interventions: Recombinant Fowlpox-CEA(6D)/TRICOM Vaccine, Recombinant Interferon Alfa-2b, Recombinant Vaccinia-CEA(6D)-TRICOM Vaccine, Sargramostim; Biological
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Sinus Node Dysfunction
Interventions: Treadmill/Bicycle exercise testing; Diagnostic Test
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Parkinson Disease
Interventions: Earstim - Active Stimulation, Earstim - Sham Stimulation; Device
Lead sponsor: Stoparkinson Healthcare Systems LLC; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 8
States / cities: Los Angeles, California • Englewood, Colorado • Boca Raton, Florida + 4 more

Conditions: Motor Activity
Interventions: Motor Learning, Somatosensory Learning, Observational Task, Mental Imagery, transcranial direct current stimulation; Behavioral · Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Nicotine Dependence
Interventions: Ad Libitum Use followed by Instructed Use of the Inspire Device, Instructed Use followed by Ad Libitum Use of the Inspire Device, Smart-T Smoking Cessation App with the Inspire Device Condition, Smart-T Smoking Cessation App Without the Inspire Device Condition, Nicotine replacement therapy (NRT), Inspire Device; Device · Drug
Lead sponsor: University of Houston; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Mild Cognitive Impairment
Interventions: iTBS rTMS; Device
Lead sponsor: Maria I. Lapid, M.D.; Other
Eligibility: 55 Years to 90 Years
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder

Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome

Subthalamic Nucleus Deep Brain Stimulation in Speech Study

Effects of Device-assisted Practice of ADL on Arm/Hand Recovery in Individuals With Moderate to Severe Stroke

Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct

Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

Investigating Accelerated Learning in Tinnitus Participants Implanted With Vagus Nerve Stimulation

Use of Noninvasive Brain Stimulation in Parkinson's Disease

Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator

Rituximab, Alemtuzumab, and GM-CSF As First-Line Therapy in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia

Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans

Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

Blinatumomab Versus Standard of Care Chemotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Accelerated High-Dose tDCS for Depression

TMS for Complex Regional Pain Syndrome

Behavioral Study to Predict the Efficacy of a Self-Help Tool

Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism

Cognitive Enhancement Through Model-based and Individualized Neurostimulation

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Effectiveness of Closed Loop Stimulation (CLS) With His Bundle Lead Placement

Auricular Muscle Zone Stimulation for Parkinson Disease

Investigating Motor Cortex Processing for Pain Modulation

Smart Olfaction App to Reduce Relapse

iTBS rTMS in Mild Cognitive Impairment